Full-Time

Medical Education Coordinator

Confirmed live in the last 24 hours

Axogen

Axogen

201-500 employees

Compensation Overview

$55.1k - $68.8k/yr

+ Bonus

Junior, Mid

Tampa, FL, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • Bachelor’s Degree (Life Sciences discipline and/or in a related field preferred)
  • Minimum of 2 years of administrative experience (project management and/or project coordination experience preferred)
  • Experience collaborating with multiple external and internal stakeholders.
  • Interpersonal skills with capability to impact and influence internal and external stakeholders.
  • Excellent communication skills, both written and verbal.
  • Ability to manage multiple priorities in a fast-paced and changing environment.
  • Capability to analyze and translate data into easily understood formats.
  • Broad scientific and technical understanding of biotechnological companies and products.
  • Willingness and ability to travel domestically up to 20% to respond to organizational needs.
  • Proficiency of MS Office applications required.
Responsibilities
  • Manages and enhances internal and external relationships with colleagues and strategic business partners
  • Assists with National and Regional educational events including, but not limited to, expense reporting, document printing, post-program surgeon evaluations, venue sourcing and Sunshine Act reporting.
  • Partners with Medical Education Team to facilitate ordering, shipping and logistics of cadaveric specimens in accordance with AATB, OSHA and Axogen Corporate policies and procedures.
  • Facilitates cadaveric specimen documentation in accordance with Axogen’s Quality and Regulatory process.
  • Responsible for monthly and quarterly demo forecasting.
  • Responsible for coordination of all demo and supplies shipments for national and regional professional education programs.
  • Assists with budget tracking, accruals and monthly finance reporting.
  • Assists with Professional Education Program metrics tracking and reporting.
  • Administration of Third Party Educational Grants and Sponsorships process: Work with compliance and external applicants to ensure all required documents are properly uploaded into the MedCompli system
  • Coordinate as needed with internal business partners to gather additional information and coordinate on site logistics and event support
  • Assist in communicating grant committee decisions to appropriate parties
  • Responsible for copy review process of Professional Education marketing materials and surgeon presentation material
  • Maintenance and distribution of Professional Education events calendar
  • Plans and coordinates in-person Professional Education department meetings.
  • Manges other projects and administrative tasks as needed.
  • Champions Company efforts to stay on the forefront of advancement in peripheral nerve repair.
  • Participates in and represent team in internal and cross functional meetings.
  • Develops and delivers presentations and reports as needed.
  • Supports educational program impact analysis monthly and quarterly.
  • Supports Medical Education staff
  • Fosters effective relationships with other functional groups and with external collaborators.
  • Delivers work in timely manner consistent with business objectives established by management
  • Complies with all federal and state laws, policies and regulations
  • Complies with all company policies, procedures and SOPs
  • Performs other duties as assigned by Supervisor.
Desired Qualifications
  • Life Sciences discipline and/or in a related field preferred
  • Project management and/or project coordination experience preferred

Company Size

201-500

Company Stage

IPO

Headquarters

Alachua, Florida

Founded

2002

Simplify Jobs

Simplify's Take

What believers are saying

  • The peripheral nerve repair market is projected to grow at a CAGR of 11.2% by 2030.
  • Increased focus on biologics drives innovation in Axogen's advanced grafts and tissue matrices.
  • AI integration in surgical planning offers potential enhancements in Axogen's product offerings.

What critics are saying

  • Leadership changes may disrupt ongoing projects or alter company focus.
  • Departure of experienced personnel could impact clinical research and development expertise.
  • Public offering of common stock may dilute existing shareholders' equity.

What makes Axogen unique

  • Axogen specializes in innovative surgical solutions for peripheral nerve injuries.
  • The company launched Avive+ Soft Tissue Matrix, a resorbable amniotic membrane allograft.
  • Axogen initiated a Biologics License Application for Avance Nerve Graft.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Holidays

Employee Stock Purchase Plan

Tuition Reimbursement

Paid Parental Leave

Paid Caregiver Leave

Basic Life Insurance

Supplemental Life Insurance

Disability Insurance

Company News

Market Wire News
Jan 10th, 2025
AXGN - Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ALACHUA, Fla. and TAMPA, Fla., Jan. 10, 2025 (GLOBE NEWSWIRE) - Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Craig Swandal as Vice President of Operations.

Investor Brand Network
Nov 7th, 2024
BioMedNewsBreaks - Annovis Bio Inc. (NYSE: ANVS) Strengthens Clinical Research Team with Appointment of Senior Clinical Scientist

Dr. Peterson, an experienced clinical researcher with a background in both academic and industry roles, joins from Axogen, where he specialized in therapies for peripheral nerve repair.

MedTech Dive
Aug 9th, 2024
Axogen names ex-Abbott exec Michael Dale as CEO

Axogen names ex-abbott exec Michael Dale as CEO.

GlobeNewswire
Jun 24th, 2024
Axogen, Inc Announces Full Launch Of Avive+ Soft Tissue Matrix(Tm)

ALACHUA, Fla. and TAMPA, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the launch of its newest product, Avive+ Soft Tissue Matrix™. Avive+™ is intended for use as a soft tissue barrier and is a resorbable, multi-layer amniotic membrane allograft that provides temporary protection and tissue separation during the critical phase of peripheral nerve healing. Avive+ is processed and distributed in accordance with U.S. Food and Drug Administration (FDA) requirements for Human Cellular and Tissue-based Products (HCT/P) under 21 CFR Part 1271 regulations, U.S

GlobeNewswire
May 16th, 2024
Axogen Inc. Initiates Rolling Submission Of Biologics License Application To U.S. Food And Drug Administration (Fda) For Avance Nerve Graft(R)

ALACHUA, Fla. and TAMPA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, is pleased to announce that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for licensure of Avance Nerve Graft® on May 15, 2024.“Today’s milestone represents a significant step in our regulatory transition of Avance Nerve Graft to a biologic,” said Karen Zaderej, chairman, CEO, and president of Axogen, Inc. “I am grateful to our Axogen team and their diligence as we work towards completing the rolling BLA submission process.”The initial submission to the U.S. FDA includes the complete non-clinical data package for the BLA